Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.13 CAD | -0.54% | -0.86% | +5.05% |
14/05 | Manulife Financial, John Hancock Collaborate With MIT AgeLab on Longevity Innovation | MT |
10/05 | Sun Life shares slump with U.S. dental biz recovering only in 2025 | RE |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- With a P/E ratio at 11.18 for the current year and 9 for next year, earnings multiples are highly attractive compared with competitors.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company has a low valuation given the cash flows generated by its activity.
- The company is one of the best yield companies with high dividend expectations.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- The group usually releases upbeat results with huge surprise rates.
Ratings chart - Surperformance
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+5.05% | 4.69TCr | - | ||
+13.16% | 7.98TCr | B- | ||
+10.59% | 5.2TCr | B+ | ||
+6.04% | 4.97TCr | B | ||
+15.32% | 4.29TCr | B+ | ||
+28.76% | 4.15TCr | B | ||
+0.65% | 2.95TCr | B | ||
-3.35% | 2.91TCr | B- | ||
-9.40% | 2.79TCr | A- | ||
+23.72% | 2.58TCr | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MFC Stock
- MFC.PR.J Stock
- Ratings Manulife Financial Corporation